Literature DB >> 24097373

Clinical, electrocardiographic, echocardiographic characteristics and long-term follow-up of elite soccer players with J-point elevation.

Luigi Biasco1, Yvonne Cristoforetti, Davide Castagno, Carla Giustetto, Piero Astegiano, Gianpasquale Ganzit, Carlo Gabriele Gribaudo, Fiorenzo Gaita.   

Abstract

BACKGROUND: J-point elevation is common in athletes; nevertheless, the influence of structural changes associated with the athlete's heart and its prognostic impact are still debated. Our aim was to investigate the prevalence of J-point elevation, the associated clinical, electrocardiographic, and echocardiographic characteristics and its impact on long-term outcome in elite soccer players. METHODS AND
RESULTS: Clinical, electrocardiographic, and cardiopulmonary exercise test data from 332 male professional soccer players were retrospectively analyzed. For 235 (70.7%) athletes echocardiographic data were also available. J-point elevation was defined as an elevation ≥1 mm in ≥2 contiguous leads. Long-term follow-up data were obtained for all athletes, whereas univariate and multivariable analyses were performed to assess the associated characteristics. Overall, 118 (35.6%) athletes showed a J-point elevation ≥1 mm. At multivariable analysis a significant direct association of interventricular septum thickness (odds ratio for 1 SD increase, 1.361; 95% confidence interval, 1.019-1.817; P=0.036) and Sokolow-Lyon index (odds ratio for 1 SD increase, 1.367; 95% confidence interval, 1.026-1.822; P=0.033) and an inverse association of baseline heart rate (odds ratio for 1 SD increase, 0.686; 95% confidence interval, 0.508-0.927; P=0.011) with J-point elevation were observed. During a long-term follow-up (median, 13.3 years; first and third quartiles, 10.1-17.0 years), a low mortality rate was observed, not related to cardiovascular causes.
CONCLUSIONS: The correlation between J-point elevation and interventricular septum thickness suggests a possible mechanistic role of exercise-induced left ventricular hypertrophy as the basis for J-point elevation. After a long-term follow-up, no cardiac death was observed.

Entities:  

Keywords:  death, sudden; electrocardiography; electrophysiology; exercise

Mesh:

Year:  2013        PMID: 24097373     DOI: 10.1161/CIRCEP.113.000434

Source DB:  PubMed          Journal:  Circ Arrhythm Electrophysiol        ISSN: 1941-3084


  5 in total

Review 1.  Early repolarization syndrome: A cause of sudden cardiac death.

Authors:  Abdi Ali; Nida Butt; Azeem S Sheikh
Journal:  World J Cardiol       Date:  2015-08-26

2.  Early Repolarisation Syndrome - New Concepts.

Authors:  Demosthenes G Katritsis; Bernard J Gersh; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2015-12-01

3.  Electrocardiograms of Children and Adolescents Practicing Non-competitive Sports: Normal Limits and Abnormal Findings in a Large European Cohort Evaluated by Telecardiology.

Authors:  Giuseppe Molinari; Natale Daniele Brunetti; Luigi Biasco; Sandro Squarcia; Yvonne Cristoforetti; Riccardo Bennicelli; Cecilia Del Vecchio; Cecilia Viacava; Carla Giustetto; Fiorenzo Gaita
Journal:  Sports Med       Date:  2017-03       Impact factor: 11.136

4.  Incidence of sudden cardiac arrest and death in young athletes and military members: a systematic review and meta-analysis.

Authors:  Aaron Lear; Niraj Patel; Chanda Mullen; Marian Simonson; Vince Leone; Constantinos Koshiaris; David Nunan
Journal:  J Athl Train       Date:  2021-05-26       Impact factor: 3.824

5.  Depolarization versus repolarization abnormality underlying inferolateral J-wave syndromes: New concepts in sudden cardiac death with apparently normal hearts.

Authors:  Michel Haïssaguerre; Koonlawee Nademanee; Mélèze Hocini; Ghassen Cheniti; Josselin Duchateau; Antonio Frontera; Frédéric Sacher; Nicolas Derval; Arnaud Denis; Thomas Pambrun; Rémi Dubois; Pierre Jaïs; David Benoist; Richard D Walton; Akihiko Nogami; Ruben Coronel; Mark Potse; Olivier Bernus
Journal:  Heart Rhythm       Date:  2018-11-02       Impact factor: 6.343

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.